174 related articles for article (PubMed ID: 17906611)
21. [Prolactin, a link between the neuroendocrine and immune systems. Role in the pathogenesis of rheumatic diseases].
Gutierez MA; Anaya JM; Cabrera GE; Vindrola O; Espinoza LR
Rev Rhum Ed Fr; 1994 Apr; 61(4):278-85. PubMed ID: 7920527
[TBL] [Abstract][Full Text] [Related]
22. [Rheumatic diseases as risk factors for cardiovascular disease].
Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
[TBL] [Abstract][Full Text] [Related]
23. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
24. Primary ovarian large B-cell lymphoma in patient with juvenile rheumatoid arthritis treated with low dose Methotrexate.
Yildirim Y
Gynecol Oncol; 2005 Apr; 97(1):249-52. PubMed ID: 15790469
[TBL] [Abstract][Full Text] [Related]
25. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
26. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
Mariette X
Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
[TBL] [Abstract][Full Text] [Related]
27. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases.
Turesson C; Matteson EL
Curr Opin Rheumatol; 2007 Mar; 19(2):190-6. PubMed ID: 17278937
[TBL] [Abstract][Full Text] [Related]
29. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
30. Musculoskeletal syndromes associated with malignancies.
Seda H; Alarcón GS
Curr Opin Rheumatol; 1995 Jan; 7(1):48-53. PubMed ID: 7718423
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
Sokol H; Beaugerie L
Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
[TBL] [Abstract][Full Text] [Related]
33. Strategies using functional genomics in rheumatic diseases.
Burmester GR; Häupl T
Autoimmun Rev; 2004 Nov; 3(7-8):541-9. PubMed ID: 15546803
[TBL] [Abstract][Full Text] [Related]
34. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
[TBL] [Abstract][Full Text] [Related]
35. Antiribosomal-P protein antibodies in a patient with systemic lupus erythematosus and non-Hodgkin's lymphoma: more than coincidental finding?
Miljic P; Bonaci-Nikolic B; Colovic N; Terzic T; Colovic M
Lupus; 2009 Jan; 18(1):81-5. PubMed ID: 19074174
[TBL] [Abstract][Full Text] [Related]
36. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
38. Emerging therapies for B-cell non-Hodgkin lymphoma.
Briones J
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1305-16. PubMed ID: 19761434
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune and inflammatory disorders and risk of malignant lymphomas--an update.
Smedby KE; Askling J; Mariette X; Baecklund E
J Intern Med; 2008 Dec; 264(6):514-27. PubMed ID: 19017176
[TBL] [Abstract][Full Text] [Related]
40. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
Voulgarelis M; Moutsopoulos HM
Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
